Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mutat Res ; 257(1): 49-89, 1991 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1987457

RESUMEN

One of the interests of ICPEMC is to identify situations in which the possible induction of inherited defects in man by mutagen exposure could actually be studied. The large-scale use of mutagenic drugs in field programmes against schistosomiasis, mainly during the 1970's, was considered a possible case. An ICPEMC task group approached the problem by (1) updating the genetic toxicology data base for antischistosomal drugs, and (2) reviewing possible study areas. Expertise was combined from genetic toxicology, mutation epidemiology and tropical medicine. It was considered that: (a) if any, hycanthone would be the most appropriate candidate drug for study; (b) it would be virtually impossible to meet the basic requirements of an appropriate mutation epidemiology study, in endemic countries; (c) as more defined genetic endpoints would be selected (e.g. sentinel phenotypes) the required large sample sizes would seem prohibitive, since documentation on past programmes is limited and local demography would render the reliable tracking of substantial numbers of offspring of treated persons an almost impossible task; (d) in most endemic countries proper diagnosis and registration of inherited defects is largely lacking; (e) the problems encountered in demonstrating inherited effects in humans after heavy or chronic exposure to established animal mutagens such as ionizing radiation and cancer chemotherapy, in combination with the ambiguous nature of the animal germ cell data with hycanthone, do not particularly warrant large expectations; (f) since non-mutagenic antischistosomal drugs are now in use, the problem is academic and of low priority in the endemic countries whose medical and research resources are often limited. Thus, studying offspring of hycanthone-treated people to demonstrate the mutagenic potential of the drug in man is not a viable enterprise.


Asunto(s)
Carcinógenos , Enfermedades Genéticas Congénitas/inducido químicamente , Mutágenos , Esquistosomicidas/toxicidad , Animales , Enfermedades Genéticas Congénitas/epidemiología , Humanos , Neoplasias/complicaciones , Neoplasias/epidemiología , Esquistosomiasis/complicaciones , Esquistosomiasis/tratamiento farmacológico , Esquistosomiasis/epidemiología , Esquistosomiasis/prevención & control , Esquistosomicidas/uso terapéutico
2.
J Leukoc Biol ; 47(4): 344-54, 1990 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2319208

RESUMEN

Explanted hepatic granulomas, eosinophils obtained from the peritoneal cavity of schistosome-infected mice, schistosome egg granuloma macrophages, alveolar macrophages, and activated peritoneal macrophages obtained from Listeria-infected mice were miracidicidal when cultured at 21% oxygen. This activity was markedly attenuated at physiologic oxygen concentrations (1-15%). Catalase and superoxide dismutase blocked the miracidicidal activity of inflammatory cells but did not prevent granuloma-mediated egg killing. However, the biomimetic superoxide dismutase, copper (II) [diisopropyl salicylate]2, inhibited granuloma-mediated egg killing in a dose-dependent, apparently nontoxic manner. Thioglycollate-elicited macrophages did not kill schistosome egg miracidia even when cultured in 21% oxygen, unless pretreated with lipopolysaccharide. Isolated schistosome eggs initiated an oxidative burst in macrophages, as measured by superoxide anion production. This burst was suppressed at reduced oxygen concentrations. Thus schistosome egg miracidia can be killed nonspecifically by macrophages through the release of cytotoxic reactive oxygen intermediates triggered by the egg. This activity is not supported by the oxygen concentrations found in most tissues, with the possible exception of the lung. Schistosoma mansoni eggs, injected intraveneously and lodged in the pulmonary vasculature of mice, were killed rapidly, with a half life of 3.5 days. Eggs, injected into the mesenteric veins and lodged in the liver, remained fully viable for several weeks. The data suggest that the high oxygen tension of the lung allows for the increased production of reactive oxygen intermediates (ROI) by local inflammatory cells, which in turn increases their miracidicidal efficiency. Conversely, the relatively hypoxic environment of the liver decreases ROI production by local inflammatory cells and decreases their miracidicidal efficiency.


Asunto(s)
Granuloma/patología , Neoplasias Hepáticas/patología , Neoplasias Pulmonares/patología , Óvulo/fisiología , Oxidación-Reducción , Oxígeno/farmacología , Schistosoma/citología , Animales , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Eosinófilos/fisiología , Femenino , Granuloma/microbiología , Granuloma/fisiopatología , Inflamación , Neoplasias Hepáticas/microbiología , Neoplasias Hepáticas/fisiopatología , Neoplasias Pulmonares/microbiología , Neoplasias Pulmonares/fisiopatología , Macrófagos/fisiología , Ratones , Óvulo/efectos de los fármacos , Oxígeno/fisiología , Schistosoma/efectos de los fármacos
3.
Res Commun Chem Pathol Pharmacol ; 67(3): 349-60, 1990 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2343183

RESUMEN

We have previously observed that the interaction of an oxidant generated by polymorphonuclear leukocytes (PMNs) with (+-)-trans benzo[a]pyrene-7,8-dihydrodiol (BP-7,8-diol) resulted in covalent binding to DNA and elicited bacterial mutagenesis (PNAS 82:5194, 1985). We now report that this interaction also induces sister chromatid exchanges (SCEs) in Chinese hamster V-79 cells. This genotoxic response required stimulation of the PMNs by phorbol ester as no effect was observed with unstimulated cells. Likewise, no intrinsic activity of BP-7,8-diol alone was noted. The addition of azide, CuDIPS, or taurine markedly inhibited the induction of SCEs by the combination of BP-7,8-diol and stimulated PMNs, further suggesting the involvement of myeloperoxidase in the activation of the polycyclic aromatic hydrocarbon. The (-) isomer of BP-7,8-diol as well as 7,8-dihydro-BP were more active than (+)-BP-7,8-diol in inducing SCEs. By contrast, benzo[a]pyrene or derivatives lacking a double bond at the 9,10 position were not effective in inducing SCEs above the level seen with phorbol ester-stimulated PMNs. These observations serve to underscore the potential for myeloperoxidase-dependent activation of xenobiotics by PMNs to result in a localized genotoxic environment.


Asunto(s)
Benzo(a)pireno/toxicidad , Neutrófilos/efectos de los fármacos , Intercambio de Cromátides Hermanas/efectos de los fármacos , Acetato de Tetradecanoilforbol/farmacología , Animales , Azidas/farmacología , Benzo(a)pireno/metabolismo , Biotransformación/efectos de los fármacos , Células Cultivadas , Humanos , Neutrófilos/metabolismo , Salicilatos/farmacología , Superóxido Dismutasa/farmacología , Taurina/farmacología
5.
Mol Carcinog ; 3(4): 243-50, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-1698383

RESUMEN

The murine gene pro1 has been cloned from JB6 epidermal cell lines that are sensitive to neoplastic transformation by tumor promoters. Insensitive JB6 variants acquire susceptibility to neoplastic transformation by tumor promoters when transfected with pro1. The repetitive nature of pro1 was indicated by sequence and Southern analysis. In contrast, northern analysis of RNA from promotion-sensitive cells revealed the presence of a small pro1-hybridizing transcript. Strand-specific RNA probes implicated an RNA polymerase III (RNAPIII) coding domain in pro1 as the source of this hybridization signal. Ribonuclease protection of gel-purified pro1 RNA from JB6 variant cell lines identified a 130-nucleotide transcript. The size of this transcript is compatible with in vitro RNAPIII transcription of pro1. Deletion mapping of pro1 by exonuclease III demonstrated that the biologically active domain included the RNAPIII transcription unit. RNA probes map pro1 RNA within the activity domain. These results delineate an activity domain of 597 nucleotides and suggest that a small RNA is the product of promotion-sensitivity gene pro1.


Asunto(s)
Carcinógenos , Deleción Cromosómica , Proto-Oncogenes , ARN Polimerasa III/genética , Alelos , Animales , Secuencia de Bases , Línea Celular , Mapeo Cromosómico , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , ARN/química , ARN Polimerasa III/biosíntesis , Mapeo Restrictivo , Ribonucleasas , Sensibilidad y Especificidad , Transcripción Genética
6.
Photochem Photobiol ; 50(5): 625-32, 1989 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-2695948

RESUMEN

Singlet oxygen activates the mutagenicity of several benzo[a]pyrene (BP) derivatives in the absence of mammalian metabolic action. This has been demonstrated using a separated-surface-sensitizer system for generating chemically pure singlet oxygen, eliminating most of the complications that arise with singlet oxygen generation by conventional photosensitization. Salmonella typhimurium bacteria were exposed to singlet oxygen in the presence of certain BP derivatives and the mutation frequency determined with an azaguanine forward mutation assay. The mutation frequency was increased by exposure to singlet oxygen compared to light-only controls for those BP derivatives that were saturated at either the 7,8 or 9,10 positions but not both. The increase in mutation frequency depends on both the concentration of BP derivative and on the dose of singlet oxygen. Mutation frequency was also significantly increased when bacteria were treated with a solution of trans-7,8-dihydrodiol-BP that had been separately exposed to singlet oxygen, unequivocally demonstrating that the mutagenicity is due to the formation of a product of BP derivative oxidation by singlet oxygen and that this product has a lifetime at least on the order of minutes in acetonitrile. The requirement for singlet oxygen rather than some other form of reactive oxygen was confirmed by determination of the gas phase lifetime of the intermediate responsible for activating mutagenicity. This was performed by measuring the dependence of the mutation frequency on the distance separating the sensitizer from the target. This gives a value of 88 +/- 35 ms, which is in excellent agreement with the mean value of 89 ms calculated from previous independent determinations of the gas phase lifetime of singlet oxygen reported in the literature.


Asunto(s)
Benzo(a)pireno/farmacología , Mutágenos , Oxígeno/farmacología , Dihidroxidihidrobenzopirenos/farmacología , Pruebas de Mutagenicidad , Oxígeno/administración & dosificación , Salmonella typhimurium/efectos de los fármacos , Oxígeno Singlete
7.
Gene ; 68(1): 63-72, 1988 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-3146526

RESUMEN

The murine gene pro1 confers susceptibility to tumor promoters upon transfection into an insensitive host cell. Nucleotide analysis over a minimally active domain of 1049 bp reveals signals expected for a gene transcribed by RNA polymerase II (RNAPII). Similar analysis of the complementary strand shows intragenic signals characteristic of genes transcribed by RNA polymerase III (RNAPIII). We have previously characterized a small, pro1-homologous transcript that is constitutively expressed at lower levels in promotion-insensitive JB6 epidermal cells as compared to promotion-sensitive and transformed clonal variants. To identify whether the pro1 RNAPII or RNAPIII transcription unit encodes the pro1-homologous RNA, RNA probes specific for each of the predicted transcripts were generated. The RNA probe specific for the pro1 RNAPIII transcription unit was found to detect the pro1-hybridizing RNA. Ligating the pro1 RNAPII 5'-flanking region to an interferon gamma reporter sequence failed to induce synthesis of the reporter protein. In addition, pro1 transcripts generated from the predicted RNAPII and RNAPIII transcription units were untranslatable in rabbit reticulocyte lysates. These data are consistent with pro1 associated tumor promotion occurring not through an RNAPII intermediate, but through an RNAPIII intermediate.


Asunto(s)
Carcinógenos/farmacología , ARN Polimerasas Dirigidas por ADN/metabolismo , Genes/efectos de los fármacos , ARN Polimerasa III/metabolismo , Transcripción Genética , Animales , Células Cultivadas , Vectores Genéticos , Interferón gamma/genética , Ratones , Hibridación de Ácido Nucleico , Plásmidos , Biosíntesis de Proteínas , Transfección
8.
Res Commun Chem Pathol Pharmacol ; 60(3): 291-307, 1988 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-3175329

RESUMEN

Changes in the extent and pattern of benzo(a)pyrene metabolism were investigated in lungs isolated from rats following ozone exposures that are associated with the proliferation of alveolar and bronchiolar epithelia. Radiolabel incorporation into metabolic products were determined at the end of 60 min perfusions with 50-55 nmol of [6-3H] [7, 10-14C] benzo(a)pyrene (BaP), which in unexposed lungs resulted in a total BaP utilization of 0.77 +/- 0.05 nmol [14C] BaP/h/lung, recovered bound to tissue macromolecules (12%), as tissue and perfusate ethyl acetate-soluble products (59%), and as perfusate water-soluble conjugates (29%). Total metabolism at the sixth position of the BaP molecule was indicated by a 3H2O production of 0.07 +/- 0.01 nmol BaP/h per lung, that resulted in the formation of quinones (33%), acid-hydrolysable (40%) and acid-resistant (27%) water-soluble products, indicated by 14C- minus 3H-labelling. Ozone-exposed lungs demonstrated an increased total [14C] BaP utilization to 3.05 +/- 0.05 nmol/h/lung. Although BaP metabolism to all products was increased, the proportion of metabolism involving the 6th position was enhanced from 10% to 25% of total BaP utilization, which was accounted for by relative increases in tissue retained quinones and in perfusate acid-hydrolysable conjugates. These data demonstrated that quinone formation represents a major pathway of lung polycyclic aromatic hydrocarbon metabolism that is greatly enhanced in lungs with proliferating epithelia associated with oxidant exposure.


Asunto(s)
Benzo(a)pireno/metabolismo , Pulmón/metabolismo , Ozono/farmacología , Animales , Sinergismo Farmacológico , Pulmón/efectos de los fármacos , Masculino , Perfusión , Quinonas/metabolismo , Ratas , Ratas Endogámicas
9.
Carcinogenesis ; 9(2): 203-7, 1988 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-2827903

RESUMEN

Evidence has been obtained that implicates the generation of reactive oxygen species as an early and critical event in the promotion of neoplastic transformation in mouse JB6 cells. The time courses for specific inhibition by CuZn-superoxide dismutase (CuZn-SOD) of the 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced promotion of neoplastic transformation in JB6 cells and for changes in antioxidant enzyme activities associated with TPA-exposure were examined. The antipromoting effect of CuZn-SOD was found to be critically dependent on the time of addition of CuZn-SOD relative to the start of a 14-day exposure of cells to TPA. Treatment of JB6 P+ Clone 22 and Clone 41 cells with CuZn-SOD for 18 h before, simultaneously with or up to 1 h after exposure to TPA, all inhibited promotion of transformation maximally. Delay of addition of CuZn-SOD by 2 h or more after the start of TPA treatment resulted in a marked decrease in the promotion inhibitory effect. CuZn-SOD added 24 or 48 h after TPA had no effect on promotion of transformation. Exposure of JB6 cells to 0.2- (superoxide anion radical) generated exogenously by the aerobic xanthine oxidase reaction resulted in promotion of neoplastic transformation that was prevented by concurrent addition of CuZn-SOD. Taken together these studies provide evidence that increased superoxide anion generation within the first 2 h following TPA exposure is an essential event in promotion of transformation in JB6 cells. Upon TPA exposure, JB6 Clone 41 cells exhibited time-specific activity changes in the cellular SOD, glutathione peroxidase (GSH-Px), and catalase. SOD and GSH-Px activities were reduced to 54% and 26% respectively of basal levels within 2 h of TPA treatment. GSH-Px activity recovered to basal levels within 4 h and CuZn-SOD within 48 h. Catalase activity was maximally reduced to 50% of basal within 1 h after TPA treatment and rebounded to greater than basal levels within 4 h. It is postulated that a c-kinase-dependent event induces rapid elevation of superoxide anion following TPA exposure and that this leads to reduced activity of antioxidant enzymes. Since antipromotion by exogenous CuZn-SOD is effective only during the first 2 h following TPA exposure, this suggests that the promotion-relevant 0.2- elevation is transient.


Asunto(s)
Transformación Celular Neoplásica/enzimología , Superóxido Dismutasa/antagonistas & inhibidores , Animales , Carcinógenos , Línea Celular , Transformación Celular Neoplásica/efectos de los fármacos , Glutatión Peroxidasa/antagonistas & inhibidores , Ratones , Superóxidos , Acetato de Tetradecanoilforbol
11.
Parasite Immunol ; 7(6): 567-73, 1985 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-3005948

RESUMEN

Administration of the antioxidants 2(3)-tert-butyl-4-hydroxyanisole (BHA) or 5-(P-methoxyphenyl)-3H-1,2-dithiol-3-thione (ADT) to female CD-1 mice starting 4 weeks after infection with 70 cercariae of Schistosoma mansoni resulted in a decrease in the size of the inner fibrotic region of the hepatic granuloma. The cellular composition of the granuloma was not altered by treatment with these two compounds. The administration of the specific superoxide scavenger copper diisopropylsalicylate (CuDIPS) resulted in a similar decrease in granuloma size, suggesting a role of superoxide radicals in the granulomatous response.


Asunto(s)
Anetol Tritiona/farmacología , Anisoles/farmacología , Antioxidantes/farmacología , Hidroxitolueno Butilado/farmacología , Granuloma/prevención & control , Parasitosis Hepáticas/prevención & control , Esquistosomiasis mansoni/complicaciones , Superóxidos/antagonistas & inhibidores , Animales , Quimiotaxis de Leucocito , Femenino , Radicales Libres , Granuloma/etiología , Granuloma/parasitología , Inflamación , Parasitosis Hepáticas/etiología , Ratones , Óvulo , Oxígeno/metabolismo , Salicilatos/farmacología , Schistosoma mansoni/aislamiento & purificación , Esquistosomiasis mansoni/patología , Superóxidos/fisiología , Triglicéridos/farmacología
12.
Proc Natl Acad Sci U S A ; 82(15): 5194-8, 1985 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2991910

RESUMEN

Oxidants, such as those generated by metabolically activated phagocytes in inflammation, have been implicated in the metabolic activation of carcinogens, and in this study we demonstrate that the interaction of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene (BP 7,8-dihydrodiol) with phorbol ester-stimulated polymorphonuclear leukocytes (PMNs) results in the generation of both a chemiluminescent intermediate and one that covalently binds to DNA. Cu(II)(3,5-diisopropylsalicylic acid)2 (CuDIPS), a biomimetic superoxide dismutase, and azide, a myeloperoxidase inhibitor, inhibited both of these reactions, indicating a dependency on oxygen-derived oxidants in these hydrocarbon-activation processes. Concordant with the formation of a carcinogen-DNA adduct, the admixture of BP 7,8-dihydrodiol and phorbol ester-stimulated PMNs elicited mutagenesis in Salmonella typhimurium strain TA100. 7,8-Dihydro-BP and BP cis-7,8-dihydrodiol were also mutagenic, whereas derivatives lacking a double bond at the 9,10 position were not. These results demonstrate that oxidants generated by metabolically stimulated PMNs can activate penultimate polycyclic aromatic hydrocarbons to a genotoxic metabolite and further defines a role for inflammation in carcinogenesis.


Asunto(s)
Benzopirenos/metabolismo , Dihidroxidihidrobenzopirenos , Neutrófilos/metabolismo , Azidas/farmacología , Biotransformación , ADN/metabolismo , Humanos , Inflamación , Mediciones Luminiscentes , Mutación , Neutrófilos/efectos de los fármacos , Oxidación-Reducción , Peroxidasa/antagonistas & inhibidores , Salicilatos/farmacología , Superóxidos/metabolismo , Acetato de Tetradecanoilforbol/farmacología
14.
J Natl Cancer Inst ; 73(1): 151-60, 1984 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-6204093

RESUMEN

The antischistosomal and antitrypanosomal drug trans-5-amino-3-[2-(5-nitro-2-furyl)vinyl]-1,2,4-oxadiazole [(SQ18506) CAS: 28754-68-9; (E)-amino-3-(2-(5-nitro-2-furyl)-vinyl)-1,2,4-oxadiazole] was carcinogenic for both male and female CD-1 mice when it was administered either in the diet or by gastric intubation. Dose-dependent increases in tumors of the forestomach and lymphatic tissues were observed in all groups receiving SQ18506 including mice infected with Schistosoma mansoni. The predominant tumor observed was squamous cell carcinoma of the forestomach. The presence or absence of schistosome infection did not appear to alter the incidence or distribution of tumors at comparable doses of SQ18506. The incidence of bladder tumors was positively correlated with the dose in gastric intubation studies and inversely correlated with the dose in dietary studies. The carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (CAS: 24554-26-5) was fed to male and female CD-1 mice in the diet as a positive control. The predominant tumor observed in these groups was transitional cell carcinoma of the bladder. These data indicate that SQ18506 is unsuitable for use in the treatment of parasitic diseases.


Asunto(s)
5-Amino-3-((5-nitro-2-furil)vinil)-1,2,4-oxadiazol/toxicidad , Carcinógenos , Neoplasias Experimentales/patología , Nitrofuranos/toxicidad , Esquistosomiasis/tratamiento farmacológico , 5-Amino-3-((5-nitro-2-furil)vinil)-1,2,4-oxadiazol/uso terapéutico , Envejecimiento , Animales , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Ratones , Neoplasias Experimentales/inducido químicamente , Schistosoma mansoni
15.
J Natl Cancer Inst ; 73(1): 161-8, 1984 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-6204094

RESUMEN

In an attempt to dissociate the chemotherapeutic from the carcinogenic properties of the antischistosomal and antitrypanosomal nitrovinylfuran trans-5-amino-3-[2-(5-nitro-2-furyl)vinyl]1,2,4-oxadiazole [(SQ18506) CAS: 28754-68-9; (E)-5-amino-3-(2-(5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole], potential inhibitors of carcinogenesis were administered to female outbred CD-1 mice before and during exposure to SQ18506. The compounds tested were ascorbic acid, etretinate, butylated hydroxyanisole (BHA), cysteamine hydrochloride, cysteine hydrochloride, dimercaprol, disulfiram, 1,4-dithiothreitol, reduced glutathione, and spermidine phosphate. The primary types of tumors observed were squamous cell carcinomas of the stomach and thymic and nonthymic lymphomas. BHA reduced the incidence of malignant tumors to control levels, whereas cysteine hydrochloride, spermidine phosphate, and disulfiram reduced the incidence of chemically induced tumors by 42, 34, and 32%, respectively. Although cysteamine hydrochloride and disulfiram had no or only a modest effect on the overall incidence of tumors, the data suggested possible tissue-specific anticarcinogenic properties for these agents. Of the 8 antioxidants tested, only 1 had marked anticarcinogenic properties against SQ18506. These data indicate that antioxidant properties alone cannot account for the anticarcinogenic activity of the compounds tested. Coadministration of the anticarcinogen BHA with SQ18506 also blocked the chemotherapeutic effects of this agent on female CD-1 mice infected with Schistosoma mansoni.


Asunto(s)
5-Amino-3-((5-nitro-2-furil)vinil)-1,2,4-oxadiazol/toxicidad , Antineoplásicos , Antioxidantes/uso terapéutico , Carcinógenos , Neoplasias Experimentales/prevención & control , Nitrofuranos/toxicidad , 5-Amino-3-((5-nitro-2-furil)vinil)-1,2,4-oxadiazol/antagonistas & inhibidores , Adenocarcinoma/inducido químicamente , Animales , Carcinoma de Células Escamosas/inducido químicamente , Femenino , Leucemia Experimental/inducido químicamente , Neoplasias Pulmonares/inducido químicamente , Linfoma/inducido químicamente , Ratones , Neoplasias Experimentales/inducido químicamente , Sarcoma Experimental/inducido químicamente
16.
Cancer Res ; 43(6): 2555-9, 1983 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-6850576

RESUMEN

The relationship between reactive oxygen and/or free radical species and tumor promotion was evaluated by investigating the inhibitory effects of 2(3)-tert-butyl-4-hydroxyanisole (BHA) and other antioxidants on the induction of ornithine decarboxylase (ODC) activity in mouse epidermis by a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA). Mice maintained on a diet containing 0.75% BHA for 8 days showed a 50% reduction in maximal ODC induction following treatment with TPA when compared to mice fed a control diet. Topical application of BHA (55 mumol) 30 min prior to TPA treatment (17 nmol) elicited an 80% inhibition of promoter-induced ODC activity. BHA was ineffective as an inhibitor when administered either 16 hr before or 2 hr after the promoter. The inhibition by BHA was dose dependent with a dose producing a 50% inhibition of ODC induction of 6 mumol. A structure-activity study with BHA analogues (2-tert-butyl-4-hydroxyanisole, 3-tert-butyl-4-hydroxyanisole, 2-tert-butyl-1,4-dimethoxybenzene,tert-butylhydroquinone, 4-hydroxyanisole, p-hydroquinone, phenol, and 2-tert-butyl-phenol) showed that hydroxyl and tert-butyl substituents were important determinants of inhibitory activity. A spectrum of other antioxidants were also tested. Butylated hydroxytoluene was nearly equipotent to BHA; alpha-tocopherol, propyl gallate, and disulfiram were all less potent, and L-ascorbate was inactive. None of the antioxidants affected basal ODC activity in non-TPA-treated mice. Collectively, these results demonstrate an early and direct inhibition of TPA-induced ODC activity by lipophilic phenolic antioxidants and suggest a role for reactive oxygen and/or free radical species in tumor promotion.


Asunto(s)
Anisoles/farmacología , Hidroxianisol Butilado/farmacología , Carboxiliasas/antagonistas & inhibidores , Epidermis/enzimología , Inhibidores de la Ornitina Descarboxilasa , Forboles/farmacología , Acetato de Tetradecanoilforbol/farmacología , Administración Tópica , Animales , Hidroxianisol Butilado/administración & dosificación , Hidroxianisol Butilado/análogos & derivados , Relación Dosis-Respuesta a Droga , Inducción Enzimática , Femenino , Ratones , Ornitina Descarboxilasa/biosíntesis , Factores de Tiempo
17.
Environ Health Perspect ; 45: 111-4, 1982 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-6754360

RESUMEN

The mutagenic activities of several phthalate esters have been evaluated in an 8-azaguanine resistance assay in Salmonella typhimurium. Three phthalate esters were found to be mutagenic: dimethyl phthalate, diethyl phthalate and di-n-butyl phthalate. A number of other phthalate esters were not found to be mutagenic, including di(2-ethylhexyl) phthalate, di-n-octyl phthalate, diallyl phthalate, diisobutyl phthalate and diisodecyl phthalate. A metabolite of di(2-ethylhexyl) phthalate, 2-ethylhexanol, was also noted to be mutagenic. The mutagenic activity of this agent and others in this series was dose dependent but weak. No dose-response curve exceeded more than 3.5 times background at maximally testable concentrations. A liquid suspension histidine reversion assay of dimethyl phthalate showed levels of mutagenic activity similar to that observed in the azaguanine resistance assay. The data suggest a need for further investigation of the mutagenic potential of these agents in other assay systems.


Asunto(s)
Mutágenos , Ácidos Ftálicos/toxicidad , Pruebas de Mutagenicidad , Salmonella typhimurium/efectos de los fármacos
20.
Am J Trop Med Hyg ; 28(3): 508-14, 1979 May.
Artículo en Inglés | MEDLINE | ID: mdl-572149

RESUMEN

Compounds which block the formation of the egg shell in female schistosomes are thought to have chemotherapeutic value. One of these compounds, disulfiram, when given chronically in the diet produced a 60% reduction in the mortality of mice carrying a heavy schistosome burden. This reduction in mortality was associated with an 80% decrease in granuloma formation. On the other hand, there was no decrease in the amount of periportal inflammation in drug-treated animals. While the use of this drug results in significant amelioration of schistosomal pathology, its effects are rapidly reversible, thus severely limiting its chemotherapeutic potential.


Asunto(s)
Disulfiram/uso terapéutico , Esquistosomiasis/tratamiento farmacológico , Animales , Disulfiram/toxicidad , Femenino , Intestinos/patología , Hígado/patología , Pulmón/patología , Ratones , Óvulo/efectos de los fármacos , Schistosoma mansoni/efectos de los fármacos , Esquistosomiasis/patología , Bazo/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA